Dapagliflozin/Metformin HCl (XIGDUO XR) is contraindicated in patients with: Severe renal impairment (eGFR < 30 mL/min/1.73 m2).
Metabolic acidosis; Patients with a history of any serious hypersensitivity reaction to the active substance or to any of the excipients.